Although still there is no official date for the arrival of the Spanish vaccine, little by little the appropriate steps are being taken to make that happen. Pedro Duque, Minister of Science and Innovation, pointed out that he has “great hope” that the three serums that are being developed in the Higher Council for Scientific Research (CSIC), at least one enters the phase of clinical trials before the end of the summer.
During your visit to National Center for Biotechnology (CNB-CSIC), explained that several projects of the CSIC and other Spanish scientific institutions “They are getting pretty close to the time of clinical trials”. Despite this, he avoided pronouncing on a specific deadline: “You cannot give dates, because it all depends on the results of the experiments to move on to the next phase. “
Encouraging results
For the moment, the most advanced vaccine project is the one being carried out by Mariano Esteban and Juan García Arriaza. According to the results observed in mice, the remedy is capable of protecting one hundred percent from infected rodents, and also It has been tested on other types of animals, such as macaques.
“We are very hopeful that at least one of the CSIC vaccines is in clinical trials before the end of the summer “, Duque stated. Likewise, he stressed that it is “extremely important and basic that all the documentation be submitted to the European Medicines Agency (EMA)”. In that sense, he insisted that they have to be “very good at submitting the papers to the European regulatory body to authorize the trials, “but everything is ready.”
Economic endowment
In order to carry out clinical trials of the drug of Esteban y Arriaza, the Council of Ministers authorized an item of 2.4 million euros. This money will be used for the CSIC to contract a CRO (Contract Research Organization) company, needed to support the phase 1/2 trial of the MVA-CoV2-S vaccine.
–
